Total Funding
55
45
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
97755
Rhegen is a developer of mRNA medicine and gene therapy.
About the Company
Rhegen is a research and development of mRNA medicine and gene therapy. The business creates the platform technologies needed for nucleic acid therapeutics, such as mRNA design and synthesis and non-carrier delivery, and applies these technologies to the field of drug research and development with market potential and clinical value.
